ClinConnect ClinConnect Logo
Search / Trial NCT06602661

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

Launched by SURREY THORACIC SURGERY GROUP · Sep 17, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Prospective Randomized Study Fissureless Lobectomy Prolonged Air Leak (Pal) Pulmonary Resections Hospital Length Of Stay (Los) Lung Carcinoma Echelon 3000 Stapler Endopath Stapler Line Reinforcement Video Assisted Thoracoscopic Surgery (Vats) Postoperative Outcomes Intraoperative Characteristics Randomized Control Trial (Rct) Surrey Memorial Hospital (Smh) Surrey Thoracic Surgery Group (Stsg) Digital Drainage System (Thopaz) Chest Tube Duration Hospital Readmission Patient Outcomes Bioabsorbable Buttress Material Polyglactin And Polydioxanone

ClinConnect Summary

This clinical trial is studying whether special staplers, called reinforced staplers, can help prevent a common problem after lung surgery known as Prolonged Air Leak (PAL). PAL can lead to longer hospital stays and more complications, so finding effective ways to reduce it is important. The trial will compare reinforced staplers, which are designed to make the staple line stronger, to regular staplers in patients undergoing a specific type of lung surgery called fissureless lobectomy for lung cancer.

To participate in this study, patients need to be at least 18 years old and scheduled for a fissureless lobectomy due to lung cancer. However, those who have had previous lung surgery on the same side or are undergoing the surgery for reasons other than lung cancer will not be eligible. If you join this trial, you can expect to have your surgery with either type of stapler, and researchers will monitor your recovery to see which stapler works better at preventing air leaks. This research is important for improving care and outcomes for lung cancer patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 and over.
  • Patients undergoing fissureless lobectomy for lung carcinoma.
  • Exclusion Criteria:
  • Patients suitable for sub lobar resections.
  • Patients undergoing lobectomy for indications other than lung cancer.
  • Patients with a history of pleural adhesions.
  • Patients with previous lung resection on the same side.

About Surrey Thoracic Surgery Group

The Surrey Thoracic Surgery Group is a leading clinical trial sponsor dedicated to advancing the field of thoracic surgery through innovative research and comprehensive patient care. Comprising a team of highly skilled surgeons and specialists, the group focuses on conducting rigorous clinical trials that aim to enhance surgical techniques, improve patient outcomes, and evaluate new therapies for thoracic conditions. Committed to ethical standards and patient safety, the Surrey Thoracic Surgery Group collaborates with academic institutions and healthcare organizations to foster scientific discovery and translate findings into clinical practice. Their mission is to contribute significantly to the body of knowledge in thoracic surgery while prioritizing the well-being of patients and the community.

Locations

Surrey, B.C, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported